Alzheimer's disease (AD) is a significant global health challenge with no cure and limited treatment options. With the growing global ageing of the population and no effective treatment, AD incidence and prevalence are expected to double in Europe by 2050. The central clinical challenge remains developing a reliable, safe, and effective therapeutic option to halt disease progression and prevent cognitive failure. Understanding AD pathogenesis and identifying targets to prevent, halt, or cure it is a top priority for the global research and medical communities. Aiming to improve AD pathophysiol
ePoster · Neuroscience